Summary

Cordlife’s shares rose 18% after the Health Ministry renewed its restricted license for another year, allowing it to continue storing and transferring existing cord blood units. The company is facing civil claims totaling at least $5.45 million from parents whose cord blood units were improperly stored. If ordered to pay, it could negatively impact Cordlife’s financial position.

https://www.straitstimes.com/business/companies-markets/cordlife-shares-jump-18-after-renewal-of-restricted-licence?ref=top-stories